Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Sculpher

Showing results (161-170 of 174) with videos related to

Pageof 18
Sort By:
Heart (British Cardiac Society)|August 21, 2020
Cost-effectiveness of cardiovascular imaging for stable coronary heart diseaseSimon Walker, Edward Cox, Ben Rothwell, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 9, 2011
Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trialVilija R Joyce, Paul G Barnett, Adam Chow, et al.
Open Heart|May 2, 2023
Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2Colin C Everett, Colin Berry, Gerry P McCann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?Abigail R Colson, Alec Morton, Christine Årdal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 17, 2013
Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV diseaseAhmed M Bayoumi, Paul G Barnett, Vilija R Joyce, et al.
BMC Health Services Research|April 11, 2023
A qualitative study on the feasibility and acceptability of institutionalizing health technology assessment in MalawiJoseph Mfutso-Bengo, Faless Jeremiah, Florence Kasende-Chinguwo, et al.
JAMA|August 30, 2016
Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical TrialJohn P Greenwood, David P Ripley, Colin Berry, et al.
Health Economics, Policy, and Law|September 27, 2023
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessmentVictoria Charlton, Michael DiStefano, Polly Mitchell, et al.
BMJ Open|September 11, 2020
Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at riskPhilip Aj Crosbie, Rhian Gabe, Irene Simmonds, et al.
Neuromodulation : Journal of the International Neuromodulation Society|December 14, 2011
Spinal Cord Stimulation vs. Conventional Medical Management: A Prospective, Randomized, Controlled, Multicenter Study of Patients with Failed Back Surgery Syndrome (PROCESS Study)Krishna Kumar, Richard North, Rod Taylor, et al.
Pageof 18

Showing results (161-170 of 174) with videos related to

Sort By:
Pageof 18
Heart (British Cardiac Society)|August 21, 2020
Cost-effectiveness of cardiovascular imaging for stable coronary heart diseaseSimon Walker, Edward Cox, Ben Rothwell, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|March 9, 2011
Effect of treatment interruption and intensification of antiretroviral therapy on health-related quality of life in patients with advanced HIV: a randomized, controlled trialVilija R Joyce, Paul G Barnett, Adam Chow, et al.
Open Heart|May 2, 2023
Randomised trial of stable chest pain investigation: 3-year clinical and quality of life results from CE-MARC 2Colin C Everett, Colin Berry, Gerry P McCann, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 28, 2021
Antimicrobial Resistance: Is Health Technology Assessment Part of the Solution or Part of the Problem?Abigail R Colson, Alec Morton, Christine Årdal, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 17, 2013
Cost-effectiveness of newer antiretroviral drugs in treatment-experienced patients with multidrug-resistant HIV diseaseAhmed M Bayoumi, Paul G Barnett, Vilija R Joyce, et al.
BMC Health Services Research|April 11, 2023
A qualitative study on the feasibility and acceptability of institutionalizing health technology assessment in MalawiJoseph Mfutso-Bengo, Faless Jeremiah, Florence Kasende-Chinguwo, et al.
JAMA|August 30, 2016
Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates: The CE-MARC 2 Randomized Clinical TrialJohn P Greenwood, David P Ripley, Colin Berry, et al.
Health Economics, Policy, and Law|September 27, 2023
We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessmentVictoria Charlton, Michael DiStefano, Polly Mitchell, et al.
BMJ Open|September 11, 2020
Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at riskPhilip Aj Crosbie, Rhian Gabe, Irene Simmonds, et al.
Neuromodulation : Journal of the International Neuromodulation Society|December 14, 2011
Spinal Cord Stimulation vs. Conventional Medical Management: A Prospective, Randomized, Controlled, Multicenter Study of Patients with Failed Back Surgery Syndrome (PROCESS Study)Krishna Kumar, Richard North, Rod Taylor, et al.
Pageof 18